£2.9M
The funding round will support the clinical development of the company's transdermal testosterone patch for post-menopausal women.
M
Medherant
Medherant develops novel transdermal drug delivery patches for therapeutic applications.
United Kingdom—Founded 2015
£2.9MTotal raised
Medherant is a clinical-stage pharmaceutical company developing transdermal drug delivery patches.
Categories
Founders
DH
David Haddleton
Professor of Polymer Chemistry